Per Soelberg Sørensen

Publikation

Publikationer pr. år 1983 2010 2011 2012 2013 2014 2015 2016 2017 2019

• 147 Tidsskriftartikel
• 16 Review
• 8 Bidrag til bog/antologi
• 4 Letter
• 8 Mere
  • 2 Rapport
  • 2 Kommentar/debat
  • 1 Bog
  • 1 Konferencebidrag i proceedings
  • 1 Konferenceabstrakt til konference
  • 1 Leder

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2019

  Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis

  Sellebjerg, F., Royen, L., Soelberg Sørensen, P., Oturai, A. B. & Jensen, P. E. H., 1 okt. 2019, I: Multiple Sclerosis Journal.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Chitinases 100%
  • Intermediate Filaments 76%
  • Multiple Sclerosis 61%
  • Cerebrospinal Fluid 60%
  • Light 49%
  16 Citationer (Scopus)

• Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis

  Petersen, E. R., Søndergaard, H. B., Laursen, J. H., Olsson, A. G., Börnsen, L., Soelberg Sørensen, P., Sellebjerg, F. & Bang Oturai, A., 1 aug. 2019, I: Multiple Sclerosis Journal.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Natalizumab 100%
  • HLA Antigens 63%
  • Multiple Sclerosis 61%
  • Smoking 50%
  • Relapsing-Remitting Multiple Sclerosis 28%
  11 Citationer (Scopus)
• 2018

  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

  Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., Fujihara, K., Galetta, S. L., Hartung, H. P., Kappos, L., Lublin, F. D., Marrie, R. A., Miller, A. E., Miller, D. H., Montalban, X., Mowry, E. M., & 10 flereSorensen, P. S., Tintoré, M., Traboulsee, A. L., Trojano, M., Uitdehaag, B. M. J., Vukusic, S., Waubant, E., Weinshenker, B. G., Reingold, S. C. & Cohen, J. A., feb. 2018, I: Lancet Neurology. 17, 2, s. 162-173

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Multiple Sclerosis 100%
  • Oligoclonal Bands 53%
  • Body Fluids 41%
  • Optic Nerve 39%
  • Spinal Cord 30%
  1528 Citationer (Scopus)

• Disability in progressive MS is associated with T2 lesion changes

  Ammitzbøll, C., Dyrby, T. B., Lyksborg, M., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Garde, E., Sørensen, P. S., Siebner, H. R. & Sellebjerg, F., feb. 2018, I: Multiple Sclerosis and Related Disorders. 20, s. 73-77

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Magnetic Resonance Imaging 75%
  • Chronic Progressive Multiple Sclerosis 62%
  • Anisotropy 51%
  • White Matter 41%
  2 Citationer (Scopus)

• Early versus later treatment start in multiple sclerosis: a register-based cohort study

  the Danish Multiple Sclerosis Group, 2018, I: European Journal of Neurology. 25, 10, s. 1262-e110

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Cohort Studies 77%
  • Confidence Intervals 24%
  • Therapeutics 18%
  • Mortality 15%
  26 Citationer (Scopus)

• ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

  Montalban, X., Gold, R., Thompson, A. J., Otero-Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S., & 7 flereSelmaj, K., Siva, A., Sorensen, P. S., Sormani, M. P., Thalheim, C., Wiendl, H. & Zipp, F., 1 feb. 2018, I: Multiple Sclerosis Journal. 24, 2, s. 96-120

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Pharmacology 75%
  • Guidelines 72%
  • Multiple Pregnancy 35%
  • Evidence-Based Practice 31%
  213 Citationer (Scopus)

• Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

  Amato, M. P., Derfuss, T., Hemmer, B., Liblau, R., Montalban, X., Sørensen, P. S., Miller, D. H. & 2016 ECTRIMS Focused Workshop Group, 1 apr. 2018, I: Multiple Sclerosis Journal. 24, 5, s. 590-603

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Education 71%
  • Vitamin D Deficiency 42%
  • Demyelinating Diseases 39%
  • Genetic Predisposition to Disease 38%
  38 Citationer (Scopus)

• Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study

  Comi, G., Cook, S., Rammohan, K., Soelberg Sorensen, P., Vermersch, P., Adeniji, A. K., Dangond, F. & Giovannoni, G., 1 jan. 2018, I: Therapeutic Advances in Neurological Disorders. 11, s. 1-11

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cladribine 100%
  • Relapsing-Remitting Multiple Sclerosis 85%
  • Tablets 62%
  • Magnetic Resonance Imaging 45%
  • Placebos 23%
  33 Citationer (Scopus)

  23 Downloads (Pure)

• Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

  Giovannoni, G., Soelberg Sorensen, P., Cook, S., Rammohan, K., Rieckmann, P., Comi, G., Dangond, F., Adeniji, A. K. & Vermersch, P., 1 okt. 2018, I: Multiple Sclerosis Journal. 24, 12, s. 1594-1604

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cladribine 100%
  • Relapsing-Remitting Multiple Sclerosis 85%
  • Tablets 62%
  • Safety 39%
  • Placebos 29%
  105 Citationer (Scopus)

  85 Downloads (Pure)

• Smoking affects the interferon beta treatment response in multiple sclerosis

  Petersen, E. R., Oturai, A. B., Koch-Henriksen, N., Magyari, M., Sørensen, P. S., Sellebjerg, F. & Søndergaard, H. B., 13 feb. 2018, I: Neurology. 90, 7, s. e593-e600

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • N-acetyltransferase 1 100%
  • Relapsing-Remitting Multiple Sclerosis 95%
  • Interferon-beta 89%
  • HLA Antigens 79%
  • Multiple Sclerosis 67%
  17 Citationer (Scopus)

• Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study

  Bar-Or, A., Grove, R. A., Austin, D. J., Tolson, J. M., VanMeter, S. A., Lewis, E. W., Derosier, F. J., Lopez, M. C., Kavanagh, S. T., Miller, A. E. & Sorensen, P. S., 2018, I: Neurology. 90, 20, s. e1805-e1814

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • ofatumumab 100%
  • Relapsing-Remitting Multiple Sclerosis 74%
  • B-Lymphocytes 20%
  • Placebos 18%
  • Safety 15%
  59 Citationer (Scopus)

  18 Downloads (Pure)

• Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management

  Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Giovannoni, G., Hartung, H. P., Havrdova, E., Kappos, L., Pozzilli, C., Soerensen, P. S., Tackenberg, B., Vermersch, P. & Comi, G., 2018, I: European Journal of Neurology. 25, 5, s. 739-746 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Pregnancy 100%
  • Multiple Sclerosis 70%
  • Pediatrics 51%
  • Chronic Progressive Multiple Sclerosis 41%
  • Neurologists 33%
  6 Citationer (Scopus)
• 2017

  A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod

  Koch-Henriksen, N., Magyari, M., Sellebjerg, F. & Soelberg Sørensen, P., feb. 2017, I: Multiple Sclerosis. 23, 2, s. 234-241 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Natalizumab 100%
  • Fingolimod Hydrochloride 96%
  • Multiple Sclerosis 61%
  • Relapsing-Remitting Multiple Sclerosis 57%
  • Propensity Score 37%
  32 Citationer (Scopus)

• Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships

  Thormann, A., Sørensen, P. S., Koch-Henriksen, N., Thygesen, L. C., Laursen, B. & Magyari, M., jun. 2017, I: European Journal of Neurology. 24, 6, s. 825-834 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Income 93%
  • Comorbidity 88%
  • Confidence Intervals 20%
  • Odds Ratio 16%
  15 Citationer (Scopus)

• Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

  Link, J., Ramanujam, R., Auer, M., Ryner, M., Hässler, S., Bachelet, D., Mbogning, C., Warnke, C., Buck, D., Hyldgaard Jensen, P. E., Sievers, C., Ingenhoven, K., Fissolo, N., Lindberg, R., Grummel, V., Donnellan, N., Comabella, M., Montalban, X., Kieseier, B., Soelberg Sørensen, P., & 12 flereHartung, H-P., Derfuss, T., Lawton, A., Sikkema, D., Pallardy, M., Hemmer, B., Deisenhammer, F., Broët, P., Dönnes, P., Davidson, J., Fogdell-Hahn, A. & ABIRISK Consortium, feb. 2017, I: PLOS ONE. 12, 2, 18 s., e0170395.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Interferons 100%
  • Multiple Sclerosis 87%
  • interferon-beta 83%
  • Natalizumab 80%
  • descriptive studies 77%
  21 Citationer (Scopus)

  51 Downloads (Pure)

• Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality

  Thormann, A., Sørensen, P. S., Koch-Henriksen, N., Laursen, B. & Magyari, M., 17 okt. 2017, I: Neurology. 89, 16, s. 1668-1675 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Comorbidity 88%
  • Mortality 57%
  • Preexisting Condition Coverage 9%
  • Emigration and Immigration 8%
  27 Citationer (Scopus)

• Defining active progressive multiple sclerosis

  Sellebjerg, F., Börnsen, L., Ammitzbøll, C., Nielsen, J. E., Vinther-Jensen, T., Hjermind, L. E., von Essen, M., Ratzer, R. L., Soelberg Sørensen, P. & Romme Christensen, J., 1 nov. 2017, I: Multiple Sclerosis. 23, 13, s. 1727-1735

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Myelin Basic Protein 69%
  • Intermediate Filaments 62%
  • Cerebrospinal Fluid 61%
  • Chitinases 61%
  14 Citationer (Scopus)

• Early safety and efficacy of fingolimod treatment in Denmark

  Voldsgaard, A., Koch-Henriksen, N., Magyari, M., Sellebjerg, F., Sørensen, P. S. & Oturai, A. B., 1 jan. 2017, I: Acta Neurologica Scandinavica. 135, 1, s. 129-133 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

  • Fingolimod Hydrochloride 100%
  • Denmark 76%
  • Safety 41%
  • Atrioventricular Block 15%
  • Natalizumab 9%
  12 Citationer (Scopus)

• Employment, disability pension and income for children with parental multiple sclerosis

  Moberg, J. Y., Laursen, B., Koch-Henriksen, N., Thygesen, L. C., Brødsgaard, A., Soelberg Sørensen, P. & Magyari, M., 1 jul. 2017, I: Multiple Sclerosis. 23, 8, s. 1148-1156 9 s.

  Publikation: Bidrag til tidsskrift › Letter › peer review

  • Pensions 100%
  • Multiple Sclerosis 65%
  • Income 60%
  • Child 32%
  • Odds Ratio 17%
  6 Citationer (Scopus)

• Evolving concepts in the treatment of relapsing multiple sclerosis

  Comi, G., Radaelli, M. & Soelberg Sørensen, P., 1 apr. 2017, I: Lancet. 389, 10076, s. 1347-1356

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Multiple Sclerosis 100%
  • Risk Assessment 20%
  • Therapeutics 18%
  • Neurologists 13%
  • Immune System 9%
  141 Citationer (Scopus)

• High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

  Schreiber, K., Magyari, M., Sellebjerg, F., Iversen, P., Garde, E., Madsen, C. G., Börnsen, L., Romme Christensen, J., Ratzer, R., Siebner, H. R., Laursen, B. & Soelberg Sorensen, P., 1 apr. 2017, I: Multiple Sclerosis. 23, 5, s. 675-685

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Erythropoietin 100%
  • Multiple Sclerosis 84%
  • Placebos 65%
  • Chronic Progressive Multiple Sclerosis 52%
  • Phlebotomy 22%
  22 Citationer (Scopus)

• Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials

  Sørensen, P. S., Comi, G., Vollmer, T. L., Montalban, X., Kappos, L., Dadon, Y., Gorfine, T., Margalit, M., Sasson, N., Rubinchick, S. & Knappertz, V., jan. 2017, I: International Journal of M S Care. 19, 1, s. 16-24 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • laquinimod 100%
  • Safety 31%
  • Placebos 25%
  • Cardiovascular Infections 9%
  • Mouth Diseases 7%
  8 Citationer (Scopus)

• Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents

  Blinkenberg, M. & Soelberg Sørensen, P., 1 maj 2017, I: C N S Drugs. 31, 5, s. 357-371

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Multiple Sclerosis 100%
  • Monoclonal Antibodies 82%
  • Safety 19%
  • Therapeutics 18%
  • Pathology 14%
  8 Citationer (Scopus)

• Safety concerns and risk management of multiple sclerosis therapies

  Soelberg Sorensen, P., 1 sep. 2017, I: Acta Neurologica Scandinavica. 136, 3, s. 168-186 19 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Safety Management 100%
  • Risk Management 86%
  • Multiple Sclerosis 70%
  • teriflunomide 33%
  • Dimethyl Fumarate 30%
  39 Citationer (Scopus)

• Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis

  Lundell, H., Svolgaard, O., Dogonowski, A-M., Romme Christensen, J., Selleberg, F., Soelberg Sørensen, P., Blinkenberg, M., Siebner, H. R. & Garde, E., okt. 2017, I: Acta Neurologica Scandinavica. 136, 4, s. 330-337 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Atrophy 98%
  • Spinal Cord 92%
  • Direction compound 82%
  • Cervical Cord 56%
  4 Citationer (Scopus)

• Survey of diagnostic and treatment practices for multiple sclerosis in Europe

  Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Gionvannoni, G., Hartung, H-P., Havrdova, E., Kappos, L., Pozzilli, C., Soerensen, P. S., Tackenberg, B., Vermersch, P. & Comi, G., 1 mar. 2017, I: European Journal of Neurology. 24, 3, s. 516-522

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Neurologists 83%
  • Physicians' Practice Patterns 28%
  • Relapsing-Remitting Multiple Sclerosis 23%
  • Practice Management 22%
  23 Citationer (Scopus)
• 2016

  Association between age at onset of multiple sclerosis and vitamin D level-related factors

  Laursen, J. H., Søndergaard, H. B., Sørensen, P. S., Sellebjerg, F. & Oturai, A. B., 5 jan. 2016, I: Neurology. 86, 1, s. 88-93 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Age of Onset 100%
  • Vitamin D 98%
  • Multiple Sclerosis 93%
  • HLA-DRB1 Chains 84%
  • Single Nucleotide Polymorphism 53%
  13 Citationer (Scopus)

• Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients

  Hegen, H., Adrianto, I., Lessard, C. J., Millonig, A., Bertolotto, A., Comabella, M., Giovannoni, G., Guger, M., Hoelzl, M., Khalil, M., Fazekas, F., Killestein, J., Lindberg, R. L. P., Malucchi, S., Mehling, M., Montalbán, X., Rudzki, D., Schautzer, F., Sellebjerg, F., Sorensen, P. S., & 3 flereDeisenhammer, F., Steinman, L. & Axtell, R. C., 1 apr. 2016, I: Neurology: Neuroimmunology & Neuroinflammation. 3, 2, 11 s., e202.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Interferons 100%
  • Multiple Sclerosis 96%
  • Cytokines 67%
  • Serum 18%
  • Therapeutics 17%
  21 Citationer (Scopus)

  65 Downloads (Pure)

• Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta

  Hermanrud, C., Ryner, M., Luft, T., Jensen, P. E., Ingenhoven, K., Rat, D., Deisenhammer, F., Sørensen, P. S., Pallardy, M., Sikkema, D., Bertotti, E., Kramer, D., Creeke, P. & Fogdell-Hahn, A., 2016, I: Journal of Immunological Methods. 430, s. 1-9 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Interferon-beta 100%
  • Neutralizing Antibodies 86%
  • Reporter Genes 85%
  • Luciferases 80%
  • Anti-Idiotypic Antibodies 72%
  8 Citationer (Scopus)

• Educational achievements of children of parents with multiple sclerosis: A nationwide register-based cohort study

  Moberg, J. Y., Magyari, M., Koch-Henriksen, N., Thygesen, L. C., Laursen, B. & Soelberg Sørensen, P., nov. 2016, I: Journal of Neurology. 263, 11, s. 2229-2237 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Educational Status 100%
  • Multiple Sclerosis 69%
  • Parents 58%
  • Cohort Studies 53%
  • Child 34%
  5 Citationer (Scopus)

• Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO

  Soelberg Sorensen, P., 2016, I: Multiple Sclerosis. 22, 10, s. 1260-1263 4 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  4 Citationer (Scopus)

• Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

  Macdonell, R., Nagels, G., Laplaud, D-A., Pozzilli, C., de Jong, B., Martins da Silva, A., Nicholas, R., Lechner-Scott, J. S., Gaebler, J. A., Agarwal, S., Wang, P., Yeh, M., Hovenden, M. & Soelberg Sørensen, P., 1 jun. 2016, I: Multiple Sclerosis. 22, 7, s. 944-954 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Health 55%
  • Walking 24%
  • 4-Aminopyridine 18%
  • Walking Speed 16%
  16 Citationer (Scopus)

• Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort

  Thormann, A., Koch-Henriksen, N., Laursen, B., Sørensen, P. S. & Magyari, M., 2016, I: Multiple Sclerosis and Related Disorders. 10, s. 181-186 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • Comorbidity 88%
  • Lung Diseases 33%
  • Population Control 22%
  • Neoplasms 18%
  10 Citationer (Scopus)

• Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study

  Sørensen, P. S., Sellebjerg, F., Lycke, J., Färkkilä, M., Créange, A., Lund, C. G., Schluep, M., Fredriksen, J. L., Stenager, E., Pfleger, C., Garde, E., Kinnunen, E. & Marhardt, K., 1 maj 2016, I: European Journal of Neurology. 23, 5, s. 861-870 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Minocycline 100%
  • Interferons 73%
  • Multiple Sclerosis 71%
  • Placebos 39%
  • Relapsing-Remitting Multiple Sclerosis 28%
  23 Citationer (Scopus)

• Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis

  Ratzer, R., Iversen, P., Börnsen, L., Dyrby, T. B., Christensen, J. R., Ammitzbøll, C., Madsen, C. G., Garde, E., Lyksborg, M., Andersen, B., Hyldstrup, L., Sørensen, P. S., Siebner, H. R. & Sellebjerg, F., 1 jun. 2016, I: Multiple Sclerosis Journal. 22, 7, s. 926–934 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Methylprednisolone 100%
  • Multiple Sclerosis 78%
  • Cerebrospinal Fluid 64%
  • Osteopontin 35%
  • Diffusion Tensor Imaging 33%
  20 Citationer (Scopus)

• Multiple sclerosis: Generic glatiramer acetate-a step toward cheaper MS drugs?

  Sørensen, P. S., 2016, I: Nature Reviews. Neurology. 12, 1, s. 5-6 2 s.

  Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

  7 Citationer (Scopus)

• Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies

  George, M. F., Briggs, F. B. S., Shao, X., Gianfrancesco, M. A., Kockum, I., Harbo, H. F., Celius, E. G., Bos, S. D., Hedström, A. K., Shen, L., Bernstein, A., Alfredsson, L., Hillert, J., Olsson, T., Patsopoulos, N. A., De Jager, P. L., Oturai, A. B., Søndergaard, H. B., Sellebjerg, F., Sorensen, P. S., & 14 flereGomez, R., Caillier, S. J., Cree, B. A. C., Oksenberg, J. R., Hauser, S. L., D'alfonso, S., Leone, M. A., Martinelli-Boneschi, F., Sorosina, M., van der Mei, I., Taylor, B. V., Zhou, S-Y., Schaefer, C. A. & Barcellos, L. F., 1 aug. 2016, I: Neurology: Genetics. 2, 4, 13 s., e87.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Multiple Sclerosis 100%
  • HLA-DRB1 Chains 30%
  • Age of Onset 21%
  • Single Nucleotide Polymorphism 19%
  • Meta-Analysis 16%
  43 Citationer (Scopus)

  46 Downloads (Pure)

• Neurofilament in CSF—A biomarker of disease activity and long-term prognosis in multiple sclerosis

  Soelberg Sorensen, P. & Sellebjerg, F., 2016, I: Multiple Sclerosis. 22, 9, s. 1112-1113 2 s.

  Publikation: Bidrag til tidsskrift › Leder › peer review

  12 Citationer (Scopus)

• Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

  Bachelet, D., Hässler, S., Mbogning, C., Link, J., Ryner, M., Ramanujam, R., Auer, M., Jensen, P. E. H., Koch-Henriksen, N., Warnke, C., Ingenhoven, K., Buck, D., Grummel, V., Lawton, A., Donnellan, N., Hincelin-Mery, A., Sikkema, D., Pallardy, M., Kieseier, B., Hemmer, B., & 8 flereHartung, H. P., Soelberg Sorensen, P., Deisenhammer, F., Dönnes, P., Davidson, J., Fogdell-Hahn, A., Broët, P. & ABIRISK Consortium, nov. 2016, I: P L o S One. 11, 11, s. 1-19 19 s., e0162752.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Interferons 100%
  • cohort analysis 88%
  • Multiple Sclerosis 87%
  • interferon-beta 83%
  • Natalizumab 80%
  24 Citationer (Scopus)

  53 Downloads (Pure)

• Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

  Otero-Romero, S., Sastre-Garriga, J., Comi, G., Hartung, H-P., Soelberg Sørensen, P., Thompson, A. J., Vermersch, P., Gold, R. & Montalbán, X., okt. 2016, I: Multiple Sclerosis. 22, 11, s. 1386-1396 11 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Multiple Sclerosis 100%
  • Systematic Reviews 83%
  • Pharmacology 75%
  • Baclofen 47%
  • nabiximols 32%
  60 Citationer (Scopus)

• Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis

  Dogonowski, A-M., Blinkenberg, M., Paulson, O. B., Sellebjerg, F., Sørensen, P. S., Siebner, H. R. & Madsen, K. H., 8 jan. 2016, I: Journal of Neurology, Neurosurgery and Psychiatry. 87, 8, s. 912-4 3 s.

  Publikation: Bidrag til tidsskrift › Letter › peer review

  6 Citationer (Scopus)

• Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis

  Petersen, E. R., Søndergaard, H. B., Oturai, A. B., Jensen, P. E. H., Sørensen, P. S., Sellebjerg, F. & Börnsen, L., nov. 2016, I: Multiple Sclerosis and Related Disorders. 10, s. 66-72 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Natalizumab 100%
  • Vascular Cell Adhesion Molecule-1 80%
  • Multiple Sclerosis 61%
  • Messenger RNA 39%
  • Serum 31%
  2 Citationer (Scopus)

• The Danish multiple sclerosis treatment register

  Magyari, M., Koch-Henriksen, N. & Sørensen, P. S., 25 okt. 2016, I: Clinical Epidemiology. 8, s. 549-552 4 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Multiple Sclerosis 100%
  • Databases 34%
  • Denmark 30%
  • Therapeutics 18%
  • Age of Onset 13%
  29 Citationer (Scopus)

• The potential role for ocrelizumab in the treatment of multiple sclerosis: Current evidence and future prospects

  Sorensen, P. S. & Blinkenberg, M., 2016, I: Therapeutic Advances in Neurological Disorders. 9, 1, s. 44-52 9 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • ocrelizumab 100%
  • Multiple Sclerosis 49%
  • Monoclonal Antibodies 27%
  • Placebos 25%
  • Relapsing-Remitting Multiple Sclerosis 23%
  62 Citationer (Scopus)

• Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark

  Thormann, A., Magyari, M., Koch-Henriksen, N., Laursen, B. & Sørensen, P. S., dec. 2016, I: Journal of Neurology. 263, 12, s. 2484-2493 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Denmark 100%
  • Multiple Sclerosis 83%
  • Comorbidity 73%
  • Blood Vessels 55%
  • Odds Ratio 18%
  23 Citationer (Scopus)

• Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab

  Laursen, J. H., Søndergaard, H. B., Sørensen, P. S., Sellebjerg, F. & Oturai, A. B., nov. 2016, I: Multiple Sclerosis and Related Disorders. 10, s. 169-173 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Natalizumab 100%
  • Relapsing-Remitting Multiple Sclerosis 86%
  • Vitamin D 64%
  • Recurrence 39%
  • Multiple Sclerosis 24%
  35 Citationer (Scopus)
• 2015

  A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

  Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Sorensen, P. S., Cutter, G., Reingold, S. C. & Trojano, M., 16 mar. 2015, I: Multiple Sclerosis. 21, 3, s. 282-293 12 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Multiple Sclerosis 100%
  • Autoimmune Diseases 98%
  • Systematic Reviews 83%
  • Incidence 55%
  • Population 44%
  76 Citationer (Scopus)

• A systematic review of the incidence and prevalence of cancer in multiple sclerosis

  Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Reingold, S. C. & Cutter, G., 16 mar. 2015, I: Multiple Sclerosis Journal. 21, 3, s. 294-304 11 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Multiple Sclerosis 100%
  • Systematic Reviews 83%
  • Incidence 55%
  • Neoplasms 36%
  • Breast Neoplasms 20%
  50 Citationer (Scopus)

• A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis

  Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Trojano, M., Cutter, G., Reingold, S. & Sorensen, P. S., 16 mar. 2015, I: Multiple Sclerosis. 21, 3, s. 318-331 14 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Peripheral Vascular Diseases 100%
  • Multiple Sclerosis 74%
  • Systematic Reviews 62%
  • Comorbidity 44%
  • Incidence 41%
  81 Citationer (Scopus)

• A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview

  Marrie, R. A., Cohen, J., Stuve, O., Trojano, M., Sørensen, P. S., Reingold, S., Cutter, G. & Reider, N., 16 mar. 2015, I: Multiple Sclerosis Journal. 21, 3, s. 263-81 19 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Multiple Sclerosis 100%
  • Comorbidity 88%
  • Systematic Reviews 83%
  • Incidence 55%
  • Central America 39%
  156 Citationer (Scopus)